|Slideshows|October 11, 2018

6 Myths About Integrative Psychiatry

As we shift from treating disease and toward supporting health, medication is merely one possible intervention in a spectrum of possible ones.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

FDA Clears Deep Transcranial Magnetic Stimulation for Adolescents With MDD

ByLeah Kuntz

November 14th 2025

Positive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD

ByLeah Kuntz

October 28th 2025

Tardive Dyskinesia in Older Adults: Identification and Management in Long-Term Care Settings

ByAmita R. Patel, MD, CMD, MHA, CPE

October 23rd 2025

Rights and Risks in Geriatric Capacity Assessment

ByKaren Reimers, MD

October 22nd 2025

Insomnia in Older Adults: A Holistic Approach

ByEbony Dix, MD,Shilpa Srinivasan, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

October 21st 2025

Latest CME

In-Person Event

Southern Florida Psychiatry Conference

November 21-22, 2025

Register now!

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

6 Myths About Integrative Psychiatry

Newsletter

Related Content

FDA Clears Deep Transcranial Magnetic Stimulation for Adolescents With MDD

Positive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD

Tardive Dyskinesia in Older Adults: Identification and Management in Long-Term Care Settings

Rights and Risks in Geriatric Capacity Assessment

Insomnia in Older Adults: A Holistic Approach

Latest CME

Southern Florida Psychiatry Conference

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Lamotrigine: An Update on Its Role in Bipolar Disorder

In Memoriam: 2 Terrible Ironies of Being a Psychiatrist

FDA Clears Deep Transcranial Magnetic Stimulation for Adolescents With MDD

Post-Hoc Analysis of Predictive Factors for Response to Adjunctive Cobenfy

“Futures Thinking”: How to Think About the Future, Part 1